Ability Pharmaceuticals SL
4 clinical trials · Sponsor
◉ Watch Ability Pharmaceuticals SL
| Record | Firm | Date |
|---|---|---|
| ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study (NCT04431258) | Ability Pharmaceuticals SL | 2021-05-06 |
Track Ability Pharmaceuticals SL automatically
Every clearance here is in the API, with alerts when new ones post.